Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2024 08:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.
May 29, 2024 08:30 ET | Source: Cytosurge AG

Le flux de travail CellEDIT de Cytosurge, basé sur sa technologie exclusive FluidFM®, reçoit une validation dans une publication évaluée par des pairs.

Le service CellEDIT représente un nouveau flux de travail tirant parti de la nanoinjection intranucléaire de composants CRISPR/Cas9 dans des cellules uniques, par l’intermédiaire de la technologie...
May 29, 2024 02:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.